What have we learned from the biological therapies in ulcerative colitis?

被引：0

作者：

Peña, AS ^{[1
]}

机构：

[1] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2001年 / 96卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1681 / 1684

页数：4

共 50 条

[1] What have we learned in dermatology from the biologic therapies?
Nickoloff, BJ
Stevens, SR
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : S143 - S151
[2] Cyclosporine in the treatment of severe, refractory ulcerative colitis; What have we learned in 15 years?
Lichtiger, S
GASTROENTEROLOGY, 2001, 120 (05) : A626 - A626
[3] Biological therapies for ulcerative colitis
Sands, BE
ACTA GASTRO-ENTEROLOGICA BELGICA, 2001, 64 (02): : 205 - 209
[4] Personalizing antiplatelet therapies: What have we learned from recent trials?
Landry, Sebastien
Tanguay, Jean-Francois
Lordkipanidze, Marie
PLATELETS, 2018, 29 (02) : 131 - 139
[5] What have we learned from β?
Bersohn, Richard
ACS Symposium Series, 2001, 770 : 19 - 33
[6] What Have We Learned from Helioseismology, What Have We Really Learned, and What Do We Aspire to Learn?
Gough, Douglas
SOLAR PHYSICS, 2013, 287 (1-2) : 9 - 41
[7] What Have We Learned from Helioseismology, What Have We Really Learned, and What Do We Aspire to Learn?
Douglas Gough
Solar Physics, 2013, 287 : 9 - 41
[8] Experimental Therapies for Ebola Virus Disease: What Have We Learned?
Hayden, Frederick G.
Friede, Martin
Bausch, Daniel G.
JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (02): : 167 - 170
[9] New therapies in Alzheimer's disease - What have we learned?
Dodel, R.
IMMUNOLOGY, 2011, 135 : 24 - 24
[10] Adjuvant therapies: what we have learned in the last 5 years
Scagliotti, Giorgio, V
Selvaggi, Giovanni
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S299 - S300

← 1 2 3 4 5 →